Site Listing

Please choose the site that is most convenient for you

Study Name: Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, Peritoneal Cancer, or Recurrent T
22 locations found